Combination Therapy of Gefitinib and Korean Herbal Medicines Could be a Beneficial Option for Patients with Non-Small-Cell Lung Cancer

Abstract

Abstract Abstract Lung cancer has a high mortality rate and is often diagnosed at the metastatic stage. Gefitinib is a targeted molecular therapeutic drug used to treat patients with non-small-cell lung cancer (NSCLC). Korean herbal medicines may also have therapeutic efficacy against lung cancer, reduce the side effects associated with ch

Keywords

• gefitinib
• geonchilgyebok-jeong
• hwanggibujeong-dan
• Korean herbal medicine
• lung cancer
• woohwanggeosa-dan